Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis.
Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis.
复制标题
DOI:
10.1038/gt.2014.101
复制
发表时间:
2015-01
期刊:
影响因子:
5.1
通讯作者:
Klein RL
中科院分区:
文献类型:
--
作者:
Jackson KL;Dayton RD;Orchard EA;Ju S;Ringe D;Petsko GA;Maquat LE;Klein RL
Nonsense-mediated mRNA decay (NMD) is an RNA surveillance mechanism that requires upframeshift protein 1 (UPF1). This study demonstrates that human UPF1 exerts protective effects in a rat paralysis model based on the amyotrophic lateral sclerosis (ALS)-associated protein, TDP-43 (transactive response DNA-binding protein 43 kDa). An adeno-associated virus vector (AAV9) was used to express TDP-43 throughout the spinal cord of rats, inducing reproducible limb paralysis, to recapitulate the paralysis in ALS. We selected UPF1 for therapeutic testing based on a genetic screen in yeast. The expression of human TDP-43 or human UPF1 in the spinal cord was titrated to less than twofold over the respective endogenous level. AAV9 human mycUPF1 clearly improved overall motor scores in rats also expressing TDP-43. The gene therapy effect of mycUPF1 was specific and reproducible compared with groups receiving either empty vector or green fluorescent protein vector controls. The gene therapy maintained forelimb motor function in rats that would otherwise become quadriplegic. This work helps validate UPF1 as a novel therapeutic for ALS and other TDP-43-related diseases and may implicate UPF1 and NMD involvement in the underlying disease mechanisms.